Percona Announces General Availability of Percona Platform
17.5.2022 19:04:00 EEST | Business Wire | Press release
Percona, a leader in open source database software and services, today announced the general availability of Percona Platform, which brings the company’s expertise with databases including MySQL®, PostgreSQL® and MongoDB® together alongside services, management and automated insights into a single product. Using the company’s experience in managing and improving some of the largest database installations in the world, Percona Platform helps users monitor, manage, secure and optimize their database instances across any infrastructure.
“Percona Platform brings the experience and expertise that we have built up over the years and puts it in the hands of developers and database administrators to use. It includes AI-powered recommendations that help users improve performance, management and security, as well as making it easier to scale up and manage their instances over time. With Percona Platform, we thought about how to improve the experience for developers and DBAs around running their data workloads, and how to help people achieve their goals faster around managing databases as part of their overall approach,” said Donnie Berkholz, Senior Vice President Product at Percona.
“Developers want to improve their efficiency and experience across their tasks, and databases are no exception. Improving this will be an area of investment for companies - whether this involves time for their staff to implement projects, or investing in cloud services to provide the tools they need. Percona’s approach to this challenge aims to provide self-managed control and internal ownership as well as the flexibility and ease of use that many companies tout with their DBaaS offerings. By offering a fully open source compatible service, Percona is looking to plug a gap in the market that many database companies are not able to cover,” commented Bradley Shimmin, Chief Analyst, AI platforms, analytics and data management at Omdia.
“There has been an explosion of data tools available to enterprises, which in turn has led to rampant fragmentation and highly complex, disjointed workflows. Organizations that prize velocity are looking for ways to integrate various data tools into their broader development workflows and monitor them. This is the opportunity that Percona Platform is built for. The combination of software and services in this space is intended to help customers better manage their database deployments,” commented Rachel Stephens, Senior Analyst, RedMonk.
“Percona has woven over a decade of open-source database expertise into a consistent, modern database experience for all organizations, from any cloud to on-premises. With Percona Platform we have built out our open source database software offerings, bolstered by automated insights, self-service operations, and the best database observability and management tools in the market. This launch will help us scale our business and create a sustainable model in the age of cloud, while respecting the freedom and accessibility that is open source. We have seen other companies turn away from open source and adopt closed source licenses in order to maximize their profitability, which we think is not in the best interests of customers. Our approach makes our expertise available to all our customers and users, putting their needs first,” added Ann Schlemmer, President at Percona.
Percona Platform is the culmination of the company’s work to expand and deliver its wide-ranging knowledge of databases into products that users can deploy quickly and use to improve their performance. As part of the launch, Percona has used its service expertise to create automated recommendation products called Advisors for customers that can help them immediately improve their results. It supports all deployment configurations, from public, private and hybrid cloud instances through to internal data center deployments. It supports both self-managed and Percona-managed instances, letting customers approach their database management in the way that suits them.
Percona Platform includes the following elements:
- Percona Portal - access to all Percona services and product expertise through one unified online portal, covering multiple databases with enterprise-level features including backup, security, management, optimization and more
- Percona Monitoring and Management (PMM) - a database management product that is fully open source itself, allowing developers and DBAs to streamline their management tasks across multiple platforms from one place
- New range of Advisors - automated insights that ensure user databases are performing at their best, including security management, configuration and performance improvements
- Private DBaaS Technical Preview - this will support companies deploying their own DBaaS internally using open source database distributions, Percona management tool PMM and Kubernetes operators for MySQL and PostgreSQL. It will also support the same approach for MongoDB. This enables users to easily provision and manage database instances on a self-service basis across development and testing instances, improving the experience for developers
- Percona Account - simplified user account management for all Percona products and services under one account
Links
- Percona Platform - https://www.percona.com/software/percona-platform
About Percona
Databases run better with Percona. Percona is the only company that delivers enterprise-class products, support and services for a range of open source databases including MySQL®, MariaDB®, MongoDB®, and PostgreSQL across traditional deployments, cloud-based platforms and hybrid IT environments. The company is committed to supporting open source as an approach to software licensing, development and deployment - its database management tools are used by millions of application developers, database administrators and IT professionals worldwide.
Percona equips businesses with the freedom to choose, the freedom to create, and the freedom to make a difference — helping them scale with speed as they grow. The company supports global brands such as PayPal, Vimeo, RockStar Games, Duolingo, Fiserv, Slack, Cisco Systems, and Rent the Runway, as well as smaller enterprises looking to maximize application performance while streamlining database efficiencies. For more information, visit www.percona.com.
Percona® is a registered trademark of Percona LLC. All other registered and unregistered trademarks in this document are the sole property of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220517006011/en/
Contact information
Press Contacts
Mark Kember
onebite for Percona
percona@onebite.co.uk
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 16:00:00 EEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 15:00:00 EEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 15:00:00 EEST | Press release
The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 500 million AGR uranium pellets and 222,000 AGR grids – which is equivalent to burning over 685 tonnes of coal, avoiding the emission of nearly 3 billion tonnes of CO2. Sp
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 14:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
